Back to search

France· FR:66567236

TROLOVOL 300 mg, comprimé pelliculé

A penicillamine product containing pénicillamine, registered in France by LABORATOIRE XO, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC M01CC01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTROLOVOL 300 mg, comprimé pelliculéATCM01CC01REGISTER NO.FR:66567236PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Penicillamine is registered in 10 of 19 countries.

Countries holding a registration under ATC M01CC01 (penicillamine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose

Penicillamine · ATC M01CC01

10 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of penicillamine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • France: $1.20 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Penicillamine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PÉNICILLAMINE
Manufacturer
LABORATOIRE XO
Country
France (FR)
ATC code
M01CC01
ATC class
Penicillamine
Defined daily dose
0.5 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400932031696
    plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
    EUR 19.04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

90 interactions on record for penicillamine.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Penicillamine · interactions on record

90 records

  • 13 severe
  • 52 moderate
  • 25 info

Most severe, free to view

  • CladribineL01BB04severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • CladribineL04AA40severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Penicillamine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All penicillamine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Bulgaria · Купренил
  • Czechia · Metalcaptase
  • Germany · Metalcaptase
  • Spain · Cupripen
  • United Kingdom (Northern Ireland) · Distamine, Penicillamine Generics Uk
  • Poland · Cuprenil
  • Slovakia · Metalcaptase, Penicillamine Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6235f115-5c55-48af-82a7-306d8910e46f
GET /v1/drugs/6235f115-5c55-48af-82a7-306d8910e46f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66567236",
  "date_amm": "1998-02-17",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "PÉNICILLAMINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about penicillamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.